Ritesh R Kotecha

23PUBLICATIONS
106CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Microbial geneticsMolecular targetsStudies in religious traditions (excl. Eastern, Jewish, Christian and Islamic traditions)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 14, 2026
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial.

|Apr 08, 2026
From diversity to function: microbiome precision in RCC.

Antonio Ocejo, Ritesh R Kotecha, Martin H Voss

|Feb 26, 2026
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors.

Sophie A Hanina, Tyler Park, Michael Lopez

|Nov 14, 2025
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs.

Treg Grubb, Pooneh Koochaki, Sayed Matar

|Mar 21, 2025
Utilization and perceptions of chaplaincy among hospitalized adults of Dharmic religions with cancer.

Rushil V Patel, Jill M Bowden, Danielle Boselli

|Mar 05, 2025
A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell Carcinoma.

Sumanta K Pal, Alice Bernard-Tessier, Peter Grell

Pageof 4

Frequent Collaborators

14 joint publications

Martin H Voss

12 joint publications

Robert J Motzer

7 joint publications

Maria Isabel Carlo

6 joint publications

Eduard Reznik